Therapeutic interventions for autosomal dominant polycystic kidney disease

Charles L Edelstein1

  • 1Division of Renal Diseases, University of Colorado Health Sciences Center, Denver, USA.

Insights

Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder leading to kidney failure. Current research focuses on clinical trials for new treatments like Tolvaptan, Octreotide, and ACE inhibitors to manage ADPKD.

Area of Science:

  • Nephrology
  • Genetics
  • Pharmacology

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is the most prevalent life-threatening hereditary condition in the U.S.
  • ADPKD leads to end-stage renal disease, necessitating dialysis or transplantation.
  • Currently, no definitive treatment exists for human ADPKD.

Purpose of the Study:

  • To review current therapeutic interventions for ADPKD.
  • To highlight ongoing clinical trials for ADPKD management.
  • To identify key drugs being investigated for ADPKD treatment.

Main Methods:

  • Review of existing literature on ADPKD treatments.
  • Analysis of ongoing clinical trials for ADPKD.
  • Identification of therapeutic agents under investigation.

Main Results:

  • Multiple clinical trials are actively testing various interventions for ADPKD in both pediatric and adult populations.
  • Key therapeutic agents under investigation include Tolvaptan, Octreotide, Sirolimus, Everolimus, statins, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARBs).

Conclusions:

  • The landscape of ADPKD treatment is evolving with numerous clinical trials underway.
  • A range of pharmacological interventions show promise for managing ADPKD progression and complications.
  • Further research and clinical data are crucial to establish effective ADPKD therapies.

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...